Given that RMR-TB composed approximately 20% of all patient episodes in this setting and 22% of MDR/RR-TB globally ( 24 ), there may be significant potential to simplify or shorten treatment for this group.
← all excerpts
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study.
1
—
—